Study Evaluating the Safety and Efficacy of AR-15512

Clinical trial NCT05285644 · COMPLETED

Trial details

NCT number: NCT05285644
Sponsor: Aerie Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Dry Eye Disease

Start date: 2022-05-09
Primary completion: 2023-07-24
Enrollment: 465

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.